← Browse by Condition
Medical Condition
immunosuppression
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT07206277
Recruiting
Fibroscan to Guide Post Transplant Immunosuppression Minimization
Enrollment
50 pts
Location
Canada
Sponsor
University of Alberta
NCT04150744 Phase 2
Recruiting
RFA Plus Carrizumab vs Carrizumab Alone for HCC
Enrollment
120 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...